Glimepiride and Biktarvy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glimepiride (glimepiride) and Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate). Common drug interactions include anxiety among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Glimepiride and Biktarvy. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Biktarvy?

Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.

On Jul, 15, 2026

23 people who take Glimepiride and Biktarvy together, and have interactions are studied.

Glimepiride and Biktarvy drug interactions.

What are the common drug interactions of Glimepiride and Biktarvy, by gender? *:

female:

Anxiety
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Emotional distress
Pain
Foot fracture
Chronic kidney disease
Osteopenia (a condition where bone mineral density is lower than normal)
Renal failure (kidney dysfunction)
Multiple fractures
Asthenia (weakness)

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Compression fracture (fracture due to pressure caused by injury)
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Mobility decreased (ability to move is reduced)
Multiple fractures
Muscular weakness (muscle weakness)
Osteopenia (a condition where bone mineral density is lower than normal)
Quality of life decreased

What are the common drug interactions of Glimepiride and Biktarvy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anxiety
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Emotional distress
Pain
Chronic kidney disease
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Multiple fractures
Renal failure (kidney dysfunction)
Blood creatinine increased
Foot fracture

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain
Chronic kidney disease
Foot fracture
Gait disturbance
Asthenia (weakness)
Multiple fractures
Osteopenia (a condition where bone mineral density is lower than normal)

60+:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Urinary tract infection
Blood glucose increased
Myopathy (a muscular disease in which the muscle fibres do not function)
Neuropathy peripheral (surface nerve damage)
Back pain
Blood creatinine increased
Chronic kidney disease
Emotional distress

What are the existing conditions these people have? *

Type 2 Diabetes: 3 people, 13.04%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 8.70%
Gastric Disorder (disease of stomach): 2 people, 8.70%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 8.70%
Depression: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and Biktarvy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously